Bio Protocol has announced the official launch and liquidity provision of Biome AI on its platform. Biome AI is a BioAgent focused on personalized microbiome health and clinical trials. Staking functionality will soon be available, enabling users to earn BioXP by staking, which can be used in the upcoming Ignition sale. Additionally, a BIO-based liquidity pool is now operational, with 70% of trading fees allocated to the project and 30% to Bio Protocol. Industry trends indicate that personalized health solutions are becoming a key focus for Web3 projects.
this-content
disclaimer-th
1H | 24H | 7D | 30D | 1Y |
---|---|---|---|---|
0.84% | 8.29% | 10.03% | 1.64% | 84.59% |